Our | Products


Leunib 50 mg





THERAPEUTIC AREA: Oncology / Hematology
ACTIVE PRINCIPLE: Dasatinib
PRESENTATION: 50 mg x 60 coated tablets
INDICATION:

  • Acute Lymphoblastic Leukemia
  • Chronic Myeloid Leukemia